Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells

Circulation Research

Volumn 83, Issue 2, 1998, Pages 210-216

  Speir, Edith ^a   Yu, Zu Xi ^a   Ferrans, Victor J ^a   Huang, Eng Shang ^c   Epstein, Stephen E ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antioxidant; Atherosclerosis; Cyclooxygenase; Herpesvirus; Salicylate

Indexed keywords

ACETYLSALICYLIC ACID; ANTIPYRETIC AGENT; ANTITHROMBOCYTIC AGENT; CYCLOOXYGENASE 2; DEXAMETHASONE; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SALICYLATE SODIUM; SCAVENGER;

ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTERY MUSCLE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY; CYTOMEGALOVIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; PRIORITY JOURNAL; PROMOTER REGION; RESTENOSIS; TRANSACTIVATION; VIRUS ATTENUATION; VIRUS INFECTION; VIRUS INFECTIVITY;

EID: 0032572621     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.2.210     Document Type: Article

References (27)

1. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
2. Speir E, Huang ES, Modali R, Leon MB, Shawl F, Finkel T, Epstein SE. Interaction of human cytomegalovirus with p53: possible role in coronary restenosis. Scand J Infect Dis Suppl. 1995;99:78-81.
3. Zhou Y F, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996;335: 624-630.
4. Melnick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA. 1990;263:2204-2207.
5. Speir E, Shibutani T, Yu ZX, Ferrans VJ, Epstein SE. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral intection. Circ Res. 1996;79:1143-1152.
6. Grilli M, Chiu JJ, Lenardo MJ. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol. 1993; 143:1-62.
7. Sambucetti LC, Cherrington JM, Wilkinson GW, Mocarski ES. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 1989;8:4251-4258.
8. Grech ED, Dodd NJ, Jackson MJ, Morrison WL, Faragher EB, Ramsdale DR. Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol. 1996;77:122-127.
9. Tanaka J, Iida H, Sato H, Hatano M. Inhibitors of prostaglandin synthesis inhibit growth of human cytomegalovirus and reactivation of latent virus in a productively and latently infected human cell line. Virology. 1988; 163:205-208.
10. AbuBakar S, Boldogh I, Albrecht T. Human cytomegalovirus stimulates arachidonic acid metabolism through pathways that are affected by inhibitors of phospholipase A2 and protein kinase C. Biochem Biophys Res Commun. 1990;166:953-959.
11. Shibutani T, Yu ZX, Ferrans VJ, Moss J, Epstein SE. Pertussis toxin sensitive G-proteins as mediators of the signal transduction pathways activated by cytomegalovirus intection of smooth muscle cells. J Clin Invest. 1997;100:2054-2061.
12. Smith WL, DeWitt DL. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol. 1995;15:170-194.
13. Crofford LJ, Tan B, McCarthy CJ, Hla T. Involvement of nuclear factor κB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum. 1997;40:226-236.
14. Alcami J, Barzu T, Michelson S. Induction of an endothelial cell growth factor by human cytomegalovirus infection of fibroblasts. J Gen Virol. 1991;72:2765-2770.
15. Yurochko AD, Kowalik TF, Huong SM, Huang ES. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol. 1995;69:5391-5400.
16. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem J. 1994;302:723-727.
17. Ristimaki A, Narko K, Hla T. Down-regulation of cytokine-induced cyclooxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J. 1996;318:325-331.
18. Weissmann G. Aspirin. Sci Am. 1991;264:84-90.
19. Sagone AL Jr, Husney RM. Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems. J Immunol. 1987;138:2177-2183.
20. Copeland RA, Williams JM, Giannaras J, Nurnberg S, Covington M, Pinto D, Pick S, Trzaskos JM. Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci USA. 1994;91:11202-11206.
21. Evett GE, Xie W, Chipman JG, Robertson DL, Simmons DL. Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: regulation by dexamethasone, mitogens, and oncogenes. Arch Biochem Biophys. 1993; 306:169-177.
22. Shin WS, Hong YH, Peng HB, DeCaterina R, Libby P, Liao JK. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-γ. J Biol Chem. 1996;271:11317-11324.
23. Jacobson MD. Reactive oxygen species and programmed cell death. Trends Biochem Sci. 1996;21:83-86.
24. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA, Smithies O. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 1995;83:473-482.
25. Wathen MW, Stinski MF. Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol. 1982;41:462-477.
26. Kopp E, Gosh S. Inhibition of NFκB by sodium salicylate and aspirin. Science. 1994;265:956-958.
27. Tardif JC, Cote G, Lesperance J, Bourassa M, Lambert J, Doucet S, Bilodeau L, Nattel S, DeGuise P. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med. 1997; 337:365-372.